NOS3 and pulmonary arterial hypertension: Disruptions in the eNOS-NO signaling axis have been implicated in the pathophysiology of various neonatal pulmonary conditions, including pulmonary hypertension and impaired oxygenation, both of which are relevant in the context of neonatal RDS [15].